Industry News

Industry News

Plasmacytoid DCs: Tumor-killing Immune Cells

Jan 18, 2012

Some skin cancers, in particular basal cell carcinoma, can be successfully treated with a prescription cream containing the compound imiquimod. The antitumor effect of imiquimod is multifactorial. One of the more complex aspects of imiquimod's antitumor effects is its ability to modify the immune response... Read More

Study Published On Novel Treatment For Skin Lymphoma

Jan 18, 2012

Promising findings on a novel combination treatment approach for a chronic type of skin lymphoma are published in JAMA's Archives of Dermatology by clinical researchers from Seidman Cancer Center at University Hospitals (UH) Case Medical Center and Case Western Reserve University School of Medicine... Read More

New Achilles Heel In Acute Myeloid Leukaemia Identified By Cell Death Researchers

Jan 18, 2012

Melbourne researchers have discovered that acute myeloid leukaemia (AML), an aggressive blood cancer with poor prognosis, may be susceptible to medications that target a protein called Mcl-1... Read More

Esophageal Cancer May Be Caused By Migration Of Cancer-Causing Stomach Cells

Jan 18, 2012

A new study is providing clues that may answer a decades-old question about the cells that give rise to a particularly lethal form of esophageal cancer... Read More

Paradoxical Discovery Finds That A Group Of Cells Known As Pericytes Help Prevent Metastasis

Jan 18, 2012

A new study finds that a group of little-explored cells in the tumor microenvironment likely serve as important gatekeepers against cancer progression and metastasis... Read More

News From The Journal Of Clinical Investigation: Jan. 17, 2012

Jan 18, 2012

VIROLOGY: How to prevent hepatitis B virus reproducing Infection with hepatitis B virus (HBV) is a major health problem worldwide, despite the fact that a highly effective preventative vaccine exists. A modified form of the immune molecule IFN-alpha is commonly used to treat individuals infected with HBV... Read More

Plasmacytoid DCs: Tumor-killing Immune Cells

Jan 18, 2012

Some skin cancers, in particular basal cell carcinoma, can be successfully treated with a prescription cream containing the compound imiquimod. The antitumor effect of imiquimod is multifactorial. One of the more complex aspects of imiquimod's antitumor effects is its ability to modify the immune response... Read More

Declines In Melanoma Deaths Limited To The Most Educated

Jan 18, 2012

A new study from the American Cancer Society finds recent declines in melanoma mortality rates in non-Hispanic Whites in the U.S. mainly reflect declines in those with the highest level of education, and reveals a widening disparity in melanoma mortality rates by education... Read More

Bladder Cancer Marker Identified By Computer Algorithm

Jan 18, 2012

Researchers at the Stanford University School of Medicine have used an innovative mathematical technique to find markers that effectively predict how deadly a cancer will be. The discovery, which in this case concerned bladder cancer, could lead to faster, less expensive and more accurate analysis of cancer risk and better treatment of the disease... Read More

NHS Cost-Cutting Could Jeopardize Cancer Care In The UK, Erode Doctor-Patient Confidence And Trust

Jan 18, 2012

A leading cancer researcher has identified very high levels of doctor-patient trust and confidence within the NHS. University of Leicester researcher Professor Paul Symonds also highlights the risk of jeopardizing this record of success if measures to become more cost effective are not carefully thought through and implemented... Read More

Previous Page   Next Page